Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Cancer Research backs ‘unique’ database

November 11, 2013 Research and Development, Sales and Marketing Cancer, Database, ICR, cansar

An oncology database – said to be the world’s largest in any disease area and funded by Cancer Research UK …
News
Genzyme image

‘Fatal’ safety concerns throw doubt on Lemtrada

November 11, 2013 Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi

An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …
News

The CDF: friend and foe?

November 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CDF, Cancer, NICE, eric low

Few things in my professional life have troubled me more than the Cancer Drugs Fund (CDF) since its inception in …
Feature
petra_wilson

New chief executive for the International Diabetes Federation

November 11, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing diabetes, petra wilson

The International Diabetes Federation (IDF) has appointed Dr Petra Wilson as its chief executive. Wilson joins IDF from Cisco, where …
Appointment
gerald_moller

Genticel appoints vice president



November 8, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing genticel, moeller

Biopharma firm Genticel has appointed Dr Gerald Moeller to sit on its supervisory Board as a vice president. Moeller has …
Appointment

Alzheimer’s drug development ‘must speed up’

November 7, 2013 Research and Development, Sales and Marketing Alzheimer's, CEO, drug development

Alzheimer’s drugs cost three times the industry average to produce, according to a new draft report – and the way …
News
shire image

Shire to cut UK research jobs says source

November 7, 2013 Research and Development, Sales and Marketing England, Shire, UK, cuts

Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …
News

Biotec Services expands with new appointments

November 7, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotec services

Clinical trials services firm Biotec Services International is expanding its presence in the US and the UK with three new …
Appointment

£10 million boost for synthetic biology

November 6, 2013 Research and Development, Sales and Marketing Biological, Synthetic, biotech

The Biotechnology and Biological Science Research Council (BBSRC) has put up £10 million which can be accessed by small companies …
News
Roche image

ImmunoGen stops cancer trial

November 6, 2013 Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche

Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …
News
dan_bradbury

Profil Institute hires former Amylin chief executive

November 6, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amylin, profil institute

Clinical research firm Profil Institute has appointed former Amylin chief executive Dan Bradbury to its Board of directors.  “Dan Bradbury …
Appointment
ABPI reception

VBP diluted, NHS drugs bill to be reduced

November 5, 2013 Medical Communications, Research and Development, Sales and Marketing Horsham, PPRS, VBP

News
novartis_st_johann_night

Nearly 400 jobs to go at UK Novartis site

November 5, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Horsham, Novartis, Sandwich

News
BIA image

UK is the go-to place for developing medicines

November 5, 2013 Research and Development, Sales and Marketing BIA, Cell Medica, ReNeuron, UK

The BioIndustry Association (BIA) has said that the UK is clearly the must-go-to location for regenerative medicine research and development. …
News
roche image

Roche strikes $550 million antibiotics deal

November 4, 2013 Research and Development, Sales and Marketing Antibiotics, Roche, WHO

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026